LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    #EFIB2022:  Industrial biotechnology community comes together in Vilnius next week

    19/10/2022
    PRESS RELEASE

    PRESS RELEASE

    Brussels, 19 October 2022 

    Leading industry leaders, SMEs representatives, start-ups, policy makers and academia are expected in Vilnius on 26-27 October, 2022 to join the 15th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB). The annual event, hosted by EuropaBio, welcomes almost 300 participants to join discussions around next generation economies and how industrial biotechnology can contribute to a more sustainable society.

    This year’s agenda amongst almost 60 speakers who will join the Conference in person and online, will feature Thierry Breton, European Commissioner for Internal Market, Virginijus Sinkevičius, European Commissioner for Environment, Oceans and Fisheries, prof. Virginijus Šikšnys, Vilnius university, and representatives from companies such as Solvay, DSM, LanzaTech, Ev Biotech and others.

    ‘EuropaBio is delighted to be hosting this year’s forum in Vilnius, with delegates joining us from across Europe. The theme ‘Next generation economies: Industrial biotechnology for a sustainable society comes at a critical time for Europe, as we experience a generational point of transition. Now is the time for the bioeconomy to achieve its full potential, driven by Europe’s powerful science base, inspirational SMEs, long term strategies in global companies and changes in consumer demand.’, says Dr Claire Skentelbery, Director General of EuropaBio.

    EFIB participants will also have the chance to meet with 14 local and international start-ups, learn about recent projects in the industrial biotechnology field at the dedicated poster presentation area and set up business meetings via EFIB Partnering tool. EuropaBio’s Executive Roundtable will bring together members and invited guests for a discussion on key recommendations to deliver a competitive bioeconomy, developed for the EFIB Vilnius Statement.

    #EFIB2022: Industrial biotechnology community comes together in Vilnius next week


    Download
    Share
    Communications Team
    Communications Team

    Related posts

    06/03/2026

    Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe


    Read more
    13/02/2026

    The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies


    Read more
    11/02/2026

    Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026


    Read more

    Important links

    • Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe
    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.